Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2024RSC Medicinal ChemistryOpen Access

Cytochrome bd oxidase: an emerging anti-tubercular drug target

View Full Paper
Ask AI
Bookmark
Share

Authors

PSPallavi SahaBanaras Hindu UniversitySDSamarpita DasIndian Institute of Engineering Science and Technology, ShibpurHIHarish K. Indurthi

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Saha et al. (2024) studied this question.

synapsesocial.com/papers/6a6a4abf26cff2e2f6f3fc2fhttps://doi.org/10.1039/d3md00587a
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Identification of 2-Aryl-Quinolone Inhibitors of Cytochrome bd and Chemical Validation of Combination Strategies for Respiratory Inhibitors against Mycobacterium tuberculosis2023 · 34 citations
  2. 2125 years after Robert Koch's discovery of the tubercle bacillus: the new XDR-TB threat. Is “science” enough to tackle the epidemic?2007 · 188 citations
  3. 3Global Tuberculosis Report 2020 – Reflections on the Global TB burden, treatment and prevention efforts2021 · 1,144 citations
  4. 4Microevolution of Cytochrome bd Oxidase in Staphylococci and Its Implication in Resistance to Respiratory Toxins Released by Pseudomonas2006 · 145 citations
  5. 5Treatment of Multidrug-Resistant Tuberculosis1993 · 711 citations